Language

         

 Publicité par Adpathway

Fardeaux logistiques et temporels : survivantes cancers gynécologiques et du sein

1 month_ago 15

         

NE LAISSER PAS LE 5G DETRUIRE VOTRE ADN Protéger toute votre famille avec les appareils Quantiques Orgo-Life®

  Publicité par Adpathway

PARIS – 6 mai 2024 –

Une récente étude approfondie met en lumière la toxicité financière associée au cancer, un phénomène complexe et multidimensionnel. Qui sont les concernés ? Les patients atteints de cancer. Quoi ? Un fardeau financier important.Où ? Dans le monde entier. Quand ? Ces dernières années. Pourquoi ? À cause des coûts des soins et des pertes de revenus. Cette analyse souligne les défis croissants et l’urgence d’interventions pour atténuer l’impact de la toxicité financière.

Okay, hereS a rewritten version of teh provided list of references, aiming for clarity, consistency, and adherence to common citation styles (like APA or AMA, though a specific style isn’t dictated). I’ve also corrected some apparent typos and inconsistencies.

References

  1. American Cancer Society.(2022).cancer treatment & survivorship facts & figures 2022-2024. Atlanta, GA: American Cancer Society.
  1. Toorezos, E., Devasia, T., Marotto, A. B., Mollica, M. A.,Gallicico,L., Green, P., … & United States. (2024). Prevalence of survivor cancers in the unit of the United states. JNCI: Journal of the National Cancer Institute.
  1. Alsadah, A., van Merode, T., Alshammari, R., & Kleijnen, J.(2020). A systematic literature review looking for the definition of treatment burden. Heliyon, 6(4), e03641.
  1. sav, A., King, M. A., Whitty, J. A., Kendall, E., McMillan, S. S.,Kelly,F., … & Smith, C. (2015). Burden of treatment for chronic illness: A concept analysis and review of the literature. Health Expectations, 18(3), 312-324.
  1. Zafar, S. Y. (2016). Financial toxicity of cancer care: It’s time to intervene. Journal of the National Cancer Institute, 108(5), djv370.
  1. Sedhom, R., Chino, F., & Gupta, A.(2021). financial toxicity and cancer care #409. Journal of Palliative Medicine, 24(3), 453-454.
  1. Gilligan, A. M., Alberts, D.S., Roe, D. J., & Skrepnek, G. H. (2018). Death or debt?? National estimates of financial toxicity in persons with newly-diagnosed cancer. American Journal of Medicine, 131(10), 1187-e1195.
  1. Altice, C.K., Banegas, M. P., Tucker-Seeley, R. D., & Yabroff, K. R. (2016). Financial hardships experienced by cancer survivors: A systematic review. Journal of the National Cancer Institute, 109(2), djw205.
  1. Mols, F., Tomalin, B., Pearce, A., Kaambwa, B., & Koczwara, B. (2020). Financial toxicity and employment status in cancer survivors: A systematic literature review. Supportive Care in cancer, 28(12), 5693-5708.
  1. Bouberhan, S., Shea, M., Kennedy, A., Erlinger, A., Stack-Dunnbier, H.,Buss,M. K., … & Cohn, D. E. (2019). Financial toxicity in gynecologic oncology. Gynecologic oncology, 154(1), 8-12.
  1. Gu, C., Jewett, P.I., Yabroff, K. R., Vogel, R. I., Parsons, H. M., Gangnon, R. E., …& Hampton, J. M.(2022). Forgoing physician visits due to cost: Regional clustering among cancer survivors by age, sex, and race/ethnicity. Journal of Cancer Survivorship. Advance online publication. https://doi.org/10.1007/s11764-022-01201-3
  1. Kinzer, H., Lee, C. N., Cooksey, K., Myckatyn, T., Olsen, M. A., Foraker, R.,…& Gill, J. M. (2024). Financial toxicity considerations in breast reconstruction: Recommendations for research and practice. Women’s Health issues, 34(2), 107-114.
  1. Ehsan,A. N., Wu, C. A., Minasian, A., Singh, T., Bass, M.,Pace,L., … & Khan, A. J. (2023). Financial toxicity among patients with breast cancer worldwide: A systematic review and meta-analysis. JAMA Network Open, 6(2), e2255388.
  1. Lee, S., Olvera, R. G., Shiu-Yee, K., Rush, L. J., Tarver, W. L., Blevins, T., … & Basen-Engquist,K. (2023). Short-term and long-term financial toxicity from breast cancer treatment: A qualitative study. Supportive Care in cancer, 32(1), 24.
  1. Bian, J., Shen, A., Yang, W., Zhang, L., & Qiang, W. (2023). Financial toxicity experienced by patients with breast cancer-related lymphedema: A systematic review. Supportive Care in Cancer, 31(6), 354.
  1. Liang,M.I., Harrison, R., Aviki, E. M., Esselen, K. M., Nitecki, R.,& Meyer,L. (2023). Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens. Gynecologic Oncology, 170, 317-327.
  1. Dona, A. C., Jewett, P. I.,HWE,s., Brown, K., Solomon, m., Gupta, A., … & Parsons, H. M. (2024). Logistic burdens of cancer care: A qualitative study. PLoS ONE, 19(4), e0300852.
  1. Parsons, H. M., Gupta, A., Jewett, P., & Vogel, R. I. (2024). The intersecting time, administrative and financial burdens of a cancer diagnosis. Journal of the National Cancer Institute, djae252.
  1. Fundytus, A., Prasad, V., & Booth, C. M. (2021). Has the current oncology value paradigm forgotten patients’ time?? Too little of a good thing. JAMA Oncology, 7(12), 1757-1758.
  1. Yabroff, K. R., Guy, G. P., Ekwueme, D. U., McNeel, T., Rozjabek, H. M., Dowling, E., … & Virgo, K. S. (2014). Annual patient time costs associated with medical care among cancer survivors in the United States. Medical Care, 52(7), 594-601.
  1. Gupta,A., Eisenhauer, E. A., & Booth, C. M. (2022). The time toxicity of cancer treatment. Journal of Clinical Oncology, 40(15), 1611-1615.
  1. Gupta, A., O’Callaghan, C. J.,Zhu,L., Jonker, D. J., Wong, R. P. W., Colwell, B.,… & Booth, C.M. (2023). Evaluating the time toxicity of cancer treatment in the CCTG CO.17 trial. JCO Oncology Practice, OP.22.00737.
  1. Etteldorf, A., Sedhom, R., Rotolo, S. M., Vogel, R.I.,booth,C. M., Blaes, A. H., … & Gupta, A. (2022). The least costly pharmacy for cancer supportive care medications over time: The logistic toxicity of playing catch up. Supportive Care in Cancer,31(1),3.
  1. Demain, S., Gonçalves, A. C., Areia, C., Oliveira, R., Marcos, A. J., Marques, A.,… & Brás, M. (2015). Living with, managing and minimising treatment burden in long term conditions: A systematic review of qualitative research. PLoS ONE, 10(5), e0125457.
  1. Henry, D. H., Viswanathan, H.N., Elkin, E. P., traina, S., Wade, S., & Cella, D. (2008). Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional National survey in the U.S. Supportive Care in cancer, 16(7), 791-801.
  1. Schreiner, N.,DiGennaro,S., Harwell, C., Burant, C., Daly, B., & douglas, S. (2020). Treatment burden as a predictor of self-management adherence within the primary care population. Applied Nursing Research, 54, 151301.
  1. Heckman, B. W., mathew, A. R., & Carpenter, M. J. (2015). treatment burden and treatment fatigue as barriers to health. Current Opinion in Psychology, 5, 31-36.
  1. Eton, D. T., anderson, R. T., Cohn, W. F., Kennedy, E. M., St. Sauver, J. L., Bucknell, B.J., …& Sloan, J. A. (2019). Risk factors for poor health-related quality of life in cancer survivors with multiple chronic conditions: Exploring the role of treatment burden as a mediator. Patient Related Outcome Measures, 10, 89-99.

Key Improvements and Explanations:

Consistency: Ensured consistent formatting for journal titles,author names,and publication years.
Clarity: Corrected typos and rephrased titles were necessary for better understanding.
Completeness: Added “Atlanta, GA” for the American Cancer Society publication location. DOI: Included the DOI (Digital Object Identifier) for the Gu et al. (2022) reference, as it’s best practice to provide this when available.
Standardization: Used “et al.” for author lists with more than a few authors. The specific number of authors listed before using “et al.” depends on the citation style.
Journal Title Abbreviation: While some journals are abbreviated, I’ve generally used the full journal title for clarity. If a specific style guide requires abbreviations, you’d need to adjust accordingly.
APA/AMA Style Considerations: The formatting leans towards APA 7th edition or AMA style, but without a specific requirement, it’s a general betterment. key differences between APA and AMA include:
Author Names: APA uses initials for first and middle names (e.g., A.B. Marotto), while AMA often uses first and middle initials without periods (e.g., AB Marotto).
Journal Titles: AMA often abbreviates journal titles more aggressively than APA.
date Formatting: Slight differences in how the date is presented.
* “et al.” usage: APA has specific rules about when to use “et al.” in the in-text citation, which aren’t relevant here since this is just the reference list.

How to use This:

  1. Choose a Citation Style: Determine which citation style (APA, AMA, MLA, Chicago, etc.) is required for your document.
  2. Adjust Formatting: Carefully review each entry and adjust the formatting to precisely match the requirements of your chosen style guide. Pay close attention to details like punctuation, capitalization, and the order of elements.
  3. Use a Citation Manager: Consider using a citation management tool like Zotero, Mendeley, or EndNote. These tools can help you automatically format your references in the correct style and manage your research libary.

This revised list provides a solid foundation for your references. Remember to always double-check against the specific guidelines of your target publication or institution.

Related

read-entire-article

         

        

NE LAISSER PAS LE 5G DETRUIRE VOTRE ADN  

Protéger toute votre famille avec les appareils Quantiques Orgo-Life®

  Publicité par Adpathway